Cargando…

Relationship between Biodistribution and Tracer Kinetics of (11)C-Erlotinib, (18)F-Afatinib and (11)C-Osimertinib and Image Quality Evaluation Using Pharmacokinetic/Pharmacodynamic Analysis in Advanced Stage Non-Small Cell Lung Cancer Patients

Background: Patients with non-small cell lung cancer (NSCLC) driven by activating epidermal growth factor receptor (EGFR) mutations are best treated with therapies targeting EGFR, i.e., tyrosine kinase inhibitors (TKI). Radiolabeled EGFR-TKI and PET have been investigated to study EGFR-TKI kinetics...

Descripción completa

Detalles Bibliográficos
Autores principales:	van de Stadt, Eveline Annette, Yaqub, Maqsood, Schuit, Robert C., Bartelink, Imke H., Leeuwerik, Anke F., Schwarte, Lothar A., de Langen, Adrianus J., Hendrikse, Harry, Bahce, Idris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032381/ https://www.ncbi.nlm.nih.gov/pubmed/35453931 http://dx.doi.org/10.3390/diagnostics12040883

Ejemplares similares

Effects of erlotinib therapy on [(11)C]erlotinib uptake in EGFR mutated, advanced NSCLC
por: Bahce, Idris, et al.
Publicado: (2016)

Quantification of [(18)F]afatinib using PET/CT in NSCLC patients: a feasibility study
por: van de Stadt, E. A., et al.
Publicado: (2020)

Radiolabeled EGFR TKI as predictive imaging biomarkers in NSCLC patients – an overview
por: Van De Stadt, Eveline, et al.
Publicado: (2022)

Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict PET Image Quality of Three Generations EGFR TKI in Advanced-Stage NSCLC Patients
por: Bartelink, I. H., et al.
Publicado: (2022)

Biodistribution and radiation dosimetry of (11)C-labelled docetaxel in cancer patients
por: van der Veldt, Astrid A. M., et al.
Publicado: (2010)

Test-Retest Variability of Relative Tracer Delivery Rate as Measured by [(11)C]PiB
por: Heeman, Fiona, et al.
Publicado: (2021)

A comparative PET imaging study with the reversible and irreversible EGFR tyrosine kinase inhibitors [(11)C]erlotinib and [(18)F]afatinib in lung cancer-bearing mice
por: Slobbe, Paul, et al.
Publicado: (2015)

Comparison of fully-automated radiosyntheses of [(11)C]erlotinib for preclinical and clinical use starting from in target produced [(11)C]CO(2) or [(11)C]CH(4)
por: Philippe, Cécile, et al.
Publicado: (2018)

Identifying erlotinib-sensitive non-small cell lung carcinoma tumors in mice using [(11)C]erlotinib PET
por: Abourbeh, Galith, et al.
Publicado: (2015)

Is there a role for sequential afatinib and osimertinib in patients with EGFR mutation?
por: Iwamoto, Natsuhiko, et al.
Publicado: (2022)

Human Biodistribution and Radiation Dosimetry of the P-Glycoprotein Radiotracer [(11)C]Metoclopramide
por: Bauer, Martin, et al.
Publicado: (2021)

Whole-Body Biodistribution, Dosimetry, and Metabolite Correction of [(11)C]Palmitate: A PET Tracer for Imaging of Fatty Acid Metabolism
por: Christensen, Nana L., et al.
Publicado: (2017)

The activation of SRC family kinases and focal adhesion kinase with the loss of the amplified, mutated EGFR gene contributes to the resistance to afatinib, erlotinib and osimertinib in human lung cancer cells
por: Murakami, Yuichi, et al.
Publicado: (2017)

Altered GABA(A) receptor density and unaltered blood–brain barrier [(11)C]flumazenil transport in drug-resistant epilepsy patients with mesial temporal sclerosis
por: Froklage, Femke E, et al.
Publicado: (2015)

[(11)C]PIB amyloid quantification: effect of reference region selection
por: Heeman, Fiona, et al.
Publicado: (2020)

Successful treatment with afatinib following the failure of osimertinib rechallenge with osimertinib-induced interstitial lung disease: A case report
por: Sato, Yozo, et al.
Publicado: (2021)

Biodistribution of [(11)C]-Metformin and mRNA Expression of Placentae Metformin Transporters in the Pregnant Chinchilla
por: Overgaard, Maria Dahl, et al.
Publicado: (2019)

Test-retest variability of quantitative [(11)C]PIB studies in Alzheimer’s disease
por: Tolboom, Nelleke, et al.
Publicado: (2009)

Afatinib plus osimertinib in the treatment of osimertinib-resistant non-small cell lung carcinoma: a phase I clinical trial
por: Miura, Satoru, et al.
Publicado: (2023)

First evaluation of PET-based human biodistribution and radiation dosimetry of (11)C-BU99008, a tracer for imaging the imidazoline(2) binding site
por: Venkataraman, Ashwin V., et al.
Publicado: (2018)

Observational Study of Sequential Afatinib and Osimertinib in EGFR Mutation-Positive NSCLC: Patients Treated with a 40-mg Starting Dose of Afatinib
por: Yamamoto, Nobuyuki, et al.
Publicado: (2019)

Human biodistribution and dosimetry of [(11)C]-UCB-J, a PET radiotracer for imaging synaptic density
por: Cawthorne, Christopher, et al.
Publicado: (2021)

The P2X(7) receptor tracer [(11)C]SMW139 as an in vivo marker of neuroinflammation in multiple sclerosis: a first-in man study
por: Hagens, Marloes H. J., et al.
Publicado: (2019)

[(11)C]AF150(S), an agonist PET ligand for M1 muscarinic acetylcholine receptors
por: Buiter, Hans JC, et al.
Publicado: (2013)

Human Biodistribution and Dosimetry of (11)C-CUMI-101, an Agonist Radioligand for Serotonin-1A Receptors in Brain
por: Hines, Christina S., et al.
Publicado: (2011)

Optimization and Biodistribution of [(11)C]-TKF, An Analog of Tau Protein Imaging Agent [(18)F]-THK523
por: Kong, Yanyan, et al.
Publicado: (2016)

Intravenous and oral whole body ketone dosimetry, biodistribution, metabolite correction and kinetics studied by (R)-[1-(11)C]β-hydroxybutyrate ([(11)C]OHB) PET in healthy humans
por: Luong, Thien Vinh, et al.
Publicado: (2023)

Quantification of the novel N-methyl-d-aspartate receptor ligand [(11)C]GMOM in man
por: van der Doef, Thalia F, et al.
Publicado: (2015)

Effectiveness of afatinib in an NSCLC patient with EGFR mutation and early progression to osimertinib: a case report
por: Nozaki, Koichiro, et al.
Publicado: (2022)

Afatinib Therapy for Brain Metastases Aggravated by a Reduction in the Dose of Erlotinib Due to the Development of Hepatotoxicity
por: Yamanaka, Yumie, et al.
Publicado: (2017)

Quantitative Assessment of Arthritis Activity in Rheumatoid Arthritis Patients Using [(11)C]DPA-713 Positron Emission Tomography
por: Yaqub, Maqsood, et al.
Publicado: (2020)

[(11)C]phenytoin revisited: synthesis by [(11)C]CO carbonylation and first evaluation as a P-gp tracer in rats
por: Verbeek, Joost, et al.
Publicado: (2012)

[(11)C]Methionine and [(11)C]PBR28 as PET Imaging Tracers to Differentiate Metastatic Tumor Recurrence or Radiation Necrosis
por: Tran, Thuy T., et al.
Publicado: (2020)

Direct comparison of [(11)C] choline and [(18)F] FET PET to detect glioma infiltration: a diagnostic accuracy study in eight patients
por: Verburg, Niels, et al.
Publicado: (2019)

Human adult and adolescent biodistribution and dosimetry of the synaptic vesicle glycoprotein 2A radioligand (11)C-UCB-J
por: Bini, Jason, et al.
Publicado: (2020)

Recent progress in [(11)C]carbon dioxide ([(11)C]CO(2)) and [(11)C]carbon monoxide ([(11)C]CO) chemistry
por: Taddei, Carlotta, et al.
Publicado: (2018)

Reproducibility of quantitative (R)-[(11)C]verapamil studies
por: van Assema, Daniëlle ME, et al.
Publicado: (2012)

Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung
por: Lu, Shun, et al.
Publicado: (2018)

Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib
por: Kim, Youjin, et al.
Publicado: (2019)

Fully-automated radiosynthesis of the amyloid tracer [(11)C] PiB via direct [(11)C]CO(2) fixation-reduction
por: Buccino, Pablo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n8lj3iq704l6c9gavqcf1cifd9